Tailored TB dosing could improve treatment outcomes

NCT ID NCT06585358

First seen Nov 21, 2025 · Last updated May 11, 2026 · Updated 20 times

Summary

This study aims to see if using a computer model to personalize the dose of TB drugs can help patients reach the right drug levels faster. About 30 adults with pulmonary tuberculosis will have their drug levels measured and doses adjusted early in treatment. The goal is to improve how well the drugs work for each individual.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TUBERCULOSIS, PULMONARY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Karolinska University Hospital

    RECRUITING

    Stockholm, 17177, Sweden

    Contact Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Linköping University Hospital

    RECRUITING

    Linköping, Sweden

    Contact Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.